|Min SIP Amount||₹500|
|NAV||₹21.18 (23 Jul 2021)|
|Fund Started||30 Nov 2018|
|Fund Size||₹1,383 Cr|
|Sun Pharmaceutical Industries Ltd.||Healthcare||Equity||9.4%|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||6.6%|
|Ipca Laboratories Ltd.||Healthcare||Equity||5.8%|
|Procter & Gamble Health Ltd.||Healthcare||Equity||5.8%|
|Max Healthcare Institute Ltd.||Healthcare||Equity||5.7%|
|Apollo Hospitals Enterprise Ltd.||Healthcare||Equity||5.5%|
|Divi's Laboratories Ltd.||Healthcare||Equity||5.4%|
|Alkem Laboratories Ltd.||Healthcare||Equity||3.9%|
DSP Healthcare Fund Direct IDCW is a Equity Mutual Fund Scheme launched by DSP Mutual Fund. This scheme was made available to investors on 30 Nov 2018. Aditya Khemka is the Current Fund Manager of DSP Healthcare Fund Direct IDCW fund.The fund currently has an Asset Under Management(AUM) of ₹1,383 Cr and the Latest NAV as of 23 Jul 2021 is ₹21.18.
The DSP Healthcare Fund Direct IDCW is rated Very High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 500. Exit load of 1% if redeemed within 12 months.
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.